Sahoo Sushanta K, Salunke Pravin, Gupta Kirti, Madan Renu
Department of Neurosurgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Br J Neurosurg. 2023 Oct;37(5):1273-1276. doi: 10.1080/02688697.2020.1849553. Epub 2020 Nov 25.
Endolymphatic sac tumors (ELST), though benign are locally invasive lesions. Owing to its vascularity, complete surgical resection is often not possible and adjuvant gamma knife radiosurgery (GKRS) is advocated to control tumor growth. These lesions do not uniformly respond to radiation therapy in the initial phase and their early radiobiological course after GKRS is less understood. We discuss a case of residual ELST where a mild increase was noted at 36 months following GKRS and then regressed completely after a decade. This report possibly has the longest follow-up revealing the true efficacy of GKRS in these tumors. ELST shows a variable response in the early years after GKRS. They may remain static, regress or increase in size. One should be aware of these patterns of early radiological responses and a long term follow up is warranted as some lesions may show radiosurgical effectiveness after a long latent period.
内淋巴囊肿瘤(ELST)虽然是良性肿瘤,但具有局部侵袭性。由于其血管丰富,通常无法进行完整的手术切除,因此主张采用辅助伽玛刀放射外科治疗(GKRS)来控制肿瘤生长。这些病变在初始阶段对放射治疗的反应并不一致,而且GKRS后其早期放射生物学过程尚不清楚。我们讨论了一例残留的ELST病例,该病例在GKRS后36个月时发现有轻度增大,随后在十年后完全消退。本报告可能是随访时间最长的,揭示了GKRS对这些肿瘤的真正疗效。ELST在GKRS后的最初几年反应不一。它们可能保持静止、缩小或增大。应了解这些早期放射学反应模式,并且有必要进行长期随访,因为一些病变可能在很长的潜伏期后才显示出放射外科治疗的效果。